Company Profile
Updated: 27-APR-06Allon Therapeutics Inc.
International public company
Ste. 506, 1168 Hamilton St., Vancouver, CANBC V6B 2S2, Canada
(604)7360634, (604)7361616 fax,
Primary SIC: Health & Allied Services Not Elsewhere, Primary NAICS: All Other Miscellaneous Ambulatory Health Care Services
Description: Medical services
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Allon Chosen as "Top 10 Partnering Candidate" and Presenting at Major Partnership Conference.(Conference news)
Marketwire Canada; 11/17/2009; 1192 words; ...Nov 17, 2009 (Marketwire via COMTEX) -- Allon Therapeutics Inc. (TSX:NPC) announced today its lead drug...administered orally or subcutaneously. About Allon Allon Therapeutics Inc. is a clinical-stage biotechnology company...
Allon Therapeutics Releases Third Quarter Operating Results.
Marketwire Canada; 11/10/2009; 2373 words; ...2009 (Marketwire via COMTEX) -- Allon Therapeutics Inc. (TSX:NPC) continues to advance...McCauley, President and CEO of Allon, said the Company expects a small...presentation On July 9, 2009, Allon released top-line data from a...
Other News To Note.
BIOWORLD Today; 11/3/2009; 1760 words; ...Acadia Pharmaceuticals Inc., of San Diego, said...April 6, 2007.) o Allon Therapeutics Inc., of Vancouver, British...neurotrophic factor. o Astex Therapeutics, of Cambridge, UK...New York-based Pfizer Inc. obtained a similar...
U.S. Patent Disclosures.
BIOWORLD Today; 11/3/2009; 1202 words; Allon Therapeutics Inc., of Vancouver, British Columbia...s glyco-engineering work. HistoRx Inc., of New Haven, Conn., was granted...biomarker analysis for pathology. Introgen Therapeutics Inc., of Austin, Texas, was awarded...
Avid Raises $26M In Series C For Molecular imaging Agents.
BIOWORLD Today; 11/3/2009; 1007 words; ...following the sale of Idun to Pfizer Inc. (See BioWorld Today, Feb...vascular occlusive diseases. o Allon Therapeutics Inc., of Vancouver, British Columbia...one common share at C$1.65. Allon is developing neuroprotective drugs...
Recent News Articles
- Global Review for Allon Therapeutics Inc.
M2 Presswire - February 27, 2008 - Allon Therapeutics Inc. Receives Increased Attention.
M2 Presswire - April 26, 2007 - CEO INTERVIEW: GORDON C. MCCAULEY - ALLON THERAPEUTICS INC. (NPC:TSX).
Wall Street Transcript Digest - September 29, 2006 - CEO INTERVIEW: GORDON MCCAULEY - ALLON THERAPEUTICS INC.
Wall Street Transcript Digest - March 20, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning